Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

Gut

Volumn 63, Issue 4, 2014, Pages 665-673

  Larrea, Esther ^a   Riezu Boj, Jose I ^a   Aldabe, Rafael ^a   Guembe, Laura ^a   Echeverria, Itziar ^a   Balasiddaiah, Anangi ^a   Gastaminza, Pablo ^b   Civeira, María Pilar ^c,d   Sarobe, Pablo ^a   Prieto, Jesus ^a,c,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 7; MESSENGER RNA; ONCOSTATIN M; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; VIRUS RNA;

ARTICLE; CANCER CELL CULTURE; CD8+ T LYMPHOCYTE; CELL NUCLEUS; CELL STIMULATION; CELL STRAIN HUH7; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPLICON; UPREGULATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS REPLICATION;

CHRONIC VIRAL HEPATITIS; GENE EXPRESSION; HCV; IMMUNE RESPONSE;

BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTORS; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7; REAL-TIME POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 84895431712     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-304377     Document Type: Article

References (35)

1. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-512. (Pubitemid 30257347)
2. Spangenberg HC, Viazov S, Kersting N, et al. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 2005;42:828-37. (Pubitemid 41401120)
3. Wedemeyer H, He XS, Nascimbeni M, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-58. (Pubitemid 35013196)
4. Makedonas G, Hutnick N, Haney D, et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 2010;6:e1000798.
5. Thimme R, Oldach D, Chang KM, et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-406. (Pubitemid 33081515)
6. Accapezzato D, Francavilla V, Paroli M, et al. Hepatic expansion of a virus-specific regulatory CD8 (+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113:963-72. (Pubitemid 38544117)
7. Gruener NH, Lechner F, Jung MC, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-8. (Pubitemid 32488148)
8. Alpdogan O, Van Den Brink MR. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 2005;26:56-64. (Pubitemid 40051993)
9. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011;11:330-42.
10. Sawa Y, Arima Y, Ogura H, et al. Hepatic interleukin-7 expression regulates T cell responses. Immunity 2009;30:447-57.
11. Pellegrini M, Calzascia T, Toe JG, et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011;144:601-13.
12. Alves NL, Hooibrink B, Arosa FA, et al. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 2003;102:2541-6. (Pubitemid 37193593)
13. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001;97:14-32. (Pubitemid 32061238)
14. Ku CC, Murakami M, Sakamoto A, et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000;288:675-8. (Pubitemid 30241571)
15. Ranson T, Vosshenrich CA, Corcuff E, et al. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci U S A 2003;100:2663-8. (Pubitemid 36297555)
16. Jakobisiak M, Golab J, Lasek W. Interleukin 15 as a promising candidate for tumor immunotherapy. Cytokine Growth Factor Rev 2011;22:99-108.
17. Budagian V, Bulanova E, Paus R, et al. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 2006;17:259-80. (Pubitemid 44038618)
18. Stonier SW, Schluns KS. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol Lett 2010;127:85-92.
19. Giri JG, Kumaki S, Ahdieh M, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995;14:3654-63.
20. Han KP, Zhu X, Liu B, et al. IL-15:receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Cytokine 2011;56:804-10.
21. Larrea E, Aldabe R, Molano E, et al. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies. Gut 2006;55:1188-96. (Pubitemid 44085689)
22. Date T, Miyamoto M, Kato T, et al. An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain. Hepatol Res 2007;37:433-43. (Pubitemid 46915788)
23. Riezu-Boj JI, Larrea E, Aldabe R, et al. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol 2011;54:422-31.
24. Larrea E, Aldabe R, Gonzalez I, et al. Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells. J Virol 2009;83:3298-311.
25. Oshima S, Nakamura T, Namiki S, et al. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells. Mol Cell Biol 2004;24:6298-310. (Pubitemid 38891131)
26. Mariner JM, Lantz V, Waldmann TA, et al. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol 2001;166:2602-9. (Pubitemid 32173498)
27. Savitsky D, Tamura T, Yanai H, et al. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 2010;59:489-510.
28. Kroger A, Koster M, Schroeder K, et al. Activities of IRF-1. J Interferon Cytokine Res 2002;22:5-14. (Pubitemid 34161278)
29. White LC, Wright KL, Felix NJ, et al. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/-mice. Immunity 1996;5:365-76. (Pubitemid 26366759)
30. Lohoff M, Duncan GS, Ferrick D, et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med 2000;192:325-36.
31. Taki S, Nakajima S, Ichikawa E, et al. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J Immunol 2005;174:6005-12. (Pubitemid 40663787)
32. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-65. (Pubitemid 32913521)
33. Kumthip K, Chusri P, Jilg N, et al. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J Virol 2012;86:8581-91.
34. Luquin E, Larrea E, Civeira MP, et al. HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway. Antiviral Res 2007;76:194-7. (Pubitemid 47410315)
35. Barritt AS 4th, Fried MW. Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus. Gastroenterology 2012;142:1314-23.